ALAN S. NIES, M.D. - Corporate Board Profile

LEXICON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2008-03-14	Alan S. Nies, M.D. has been a director since November 2003 and chairman of our medical advisory board since March 2003. ... The current members of the compensation committee are Frank P. Palantoni (chair), Philippe J. Amouyal and Alan S. Nies, M.D. ... The following table presents summary information for the year ended December 31, 2007 regarding the compensation of the non-employee members of our board of directors. ... Alan S. Nies, M.D. $31,477 Fees Earned or Paid in Cash, $57,811 Option Awards, $75,000 All Other Compensation, Total $164,288.
2009-03-13	The current members of our compensation committee are Mr. Palantoni (chair), Philippe J. Amouyal and Alan S. Nies, M.D. The board of directors, in its business judgment, has determined that Mr. Palantoni, Mr. Amouyal and Dr. Nies are “independent” in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc.
2010-03-19	The following table presents summary information for the year ended December 31, 2009 regarding the compensation of the non-employee members of our board of directors. Samuel L. Barker, Ph.D. $48,500 $14,946 — $63,446 Philippe J. Amouyal $30,500 $7,473 — $37,973 Raymond Debbane $32,000 $7,473 — $39,473 Robert J. Lefkowitz, M.D. $28,500 $7,473 $50,000 (4) $85,973 Alan S. Nies, M.D. $30,000 $7,473 $75,000 (5) $112,473 Frank P. Palantoni $37,000 $7,473 — $44,473 Christopher J. Sobecki $27,000 $7,473 — $34,473 Judith L. Swain, M.D. $29,500 $7,473 — $36,973 Kathleen M. Wiltsey $28,000 $7,473 — $35,473
2012-03-16	Alan S. Nies, M.D. has been a director since November 2003 and chairman of our medical advisory board since March 2003. Dr. Nies provides us with the benefit of his extensive clinical development experience.
2013-03-25	Alan S. Nies, M.D. has been a director since November 2003 and chairman of our medical advisory board since March 2003. ... The following table presents summary information for the year ended December 31, 2012 regarding the compensation of the non-employee members of our board of directors. ... Alan S. Nies, M.D. $31,500 Fees Earned or Paid in Cash, $25,922 Option Awards, $19,999 Restricted Stock Awards, $115,000 All Other Compensation for consulting services as chairman of medical advisory board, Total $192,421.
2014-03-14	The following table presents summary information for the year ended December 31, 2013 regarding the compensation of the non-employee members of our board of directors. Name: Alan S. Nies, M.D. Fees Earned or Paid in Cash: $28,422 Option Awards: $30,074 Restricted Stock Awards: $20,000 All Other Compensation: $115,000 Total: $193,496
2015-03-13	Alan S. Nies, M.D. has been a director since November 2003 and chairman of our medical advisory board since March 2003. Corporate Governance Committee member. Director compensation table shows $186,465 total compensation in 2014, including consulting fees.
2016-03-18	Alan S. Nies, M.D. has been a director since November 2003 ... The current members of our corporate governance committee are ... Alan S. Nies, M.D. ... Director Compensation in 2015 ... Alan S. Nies, M.D. $177,363
2017-03-17	The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Mr. Debbane, Dr. Lefkowitz and Dr. Swain are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. ... Director Compensation in 2016 ... Alan S. Nies, M.D. ... $191,707 ...
2018-03-16	Alan S. Nies, M.D. has been a director since November 2003 and chairman of our medical advisory board since March 2003. Dr. Nies provides us with the benefit of his extensive clinical development experience. The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Dr. Nies is “independent” in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. The following table presents summary information for the year ended December 31, 2017 regarding the compensation of the non-employee members of our board of directors. Alan S. Nies, M.D. received total compensation of $191,424 in 2017.
2019-03-15	Alan S. Nies, M.D. has been a director since November 2003. ... The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. ... The following table presents summary information for the year ended December 31, 2018 regarding the compensation of the non-employee members of our board of directors. ... Alan S. Nies, M.D. $25,500 Fees Earned or Paid in Cash, $14,888 Option Awards, $19,999 Restricted Stock Awards, $76,667 All Other Compensation, Total $137,054.
2020-03-13	Alan S. Nies, M.D. has been a director since November 2003. ... The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. ... The following table presents summary information for the year ended December 31, 2019 regarding the compensation of the non-employee members of our board of directors. ... Alan S. Nies, M.D. $40,440 Fees Earned or Paid in Cash, $24,460 Option Awards, $19,652 Restricted Stock Unit Awards, Total $84,552.
2021-03-19	Alan S. Nies, M.D. has been a director since November 2003. The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D.
2022-04-08	Alan S. Nies, M.D. has been a director since November 2003. Dr. Nies served in a series of senior management positions during ten years at Merck & Co. Inc. until his retirement in 2002, including senior vice president, clinical sciences. Prior to joining Merck, Dr. Nies spent fifteen years as professor of medicine and pharmacology and head of the Division of Clinical Pharmacology at the University of Colorado Health Sciences Center. Dr. Nies holds a B.S. from Stanford University and an M.D. from Harvard Medical School. Dr. Nies provides us with the benefit of his extensive clinical development experience, particularly with respect to the design, management and reporting of clinical trials, as well as his organizational and management skills developed while serving in his various leadership positions with Merck and the University of Colorado Health Sciences Center. Director Compensation in 2021: $90,621.
2023-03-17	The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Mr. Debbane, Dr. Lefkowitz and Dr. Swain are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. ... The following table presents summary information for the year ended December 31, 2022 regarding the compensation of the non-employee members of our board of directors. ... Alan S. Nies, M.D. $45,000 Fees Earned or Paid in Cash, $20,387 Option Awards, $16,465 Restricted Stock Unit Awards, Total $81,852.